Skip to content
Screener

Myriad Genetics MYGN Total Current Assets

Total Current Assets at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$3.81B-6.7%
Quest Diagnostics logo
Quest DiagnosticsDGX
$2.84B+29.4%
NeoGenomics logo
NeoGenomicsNEO
$381.48M-2.8%
Veracyte logo
VeracyteVCYT
$522.18M+36.3%
Sera Prognostics logo
Sera PrognosticsSERA
$49.73M+5.2%
Guardant Health logo
Guardant HealthGH
$1.37B+47.5%

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$310.86M-46.0%
Enterprise value$396.36M-38.7%
P/S0.4×-0.3×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 6:05 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000899923-26-000038
Line itemMarch 31,2026December 31,2025
Inventory27.930.6
Prepaid taxes2.012.0
Prepaid expenses and other current assets34.725.1
Total current assets312.8332.6
Operating lease right-of-use assets51.049.4
Property, plant and equipment, net111.5114.0
Intangible assets, net145.7153.4
Goodwill47.151.6

Item 1. Financial Statements.

FAQ

What is Myriad Genetics's total current assets?
Myriad Genetics (MYGN) reported total current assets of $312.8M in Q1 2026.
How has Myriad Genetics's total current assets changed year-over-year?
Myriad Genetics's total current assets increased by 8.9% year-over-year, from $287.2M to $312.8M.
What is the long-term trend for Myriad Genetics's total current assets?
Over 5 years (2020 to 2025), Myriad Genetics's total current assets has grown at a -3.1% compound annual growth rate (CAGR), from $389.4M to $332.6M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Myriad Genetics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude